Home › Calculator › ARCT Dividend Calculator 2026
ARCT Dividend Calculator 2026
No dividendHealthcareArcturus Therapeutics Holdings Inc. · NASDAQ
Price: $9.84 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
ARCT is not a dividend-focused stock
ARCT pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
ARCT Dividend Yield
Arcturus Therapeutics Holdings Inc. (ARCT) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When ARCT pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Arcturus Therapeutics Holdings Inc. (ARCT) — Dividend Analysis 2026
Arcturus Therapeutics Holdings Inc. is a biotechnology company focused on RNA-based medicines, developing a pipeline of vaccines for infectious diseases alongside treatments for rare liver and respiratory conditions across the United States. Its notable development programs encompass LUNAR-OTC, designed for ornithine transcarbamylase (OTC) deficiency, and LUNAR-CF, targeting cystic fibrosis lung disease caused by specific CFTR gene mutations. The company also advances vaccine initiatives such as LUNAR-COV19 and LUNAR-FLU. Arcturus has cultivated a range of strategic collaborations, including partnerships with Vinbiocare Biotechnology Joint Stock Company for manufacturing COVID-19 vaccines; Janssen Pharmaceuticals, Inc., to create nucleic acid-based therapies for hepatitis B virus; Ultragenyx Pharmaceutical, Inc., for developing mRNA therapeutics aimed at rare disease targets; CureVac AG, to progress mRNA therapeutic and vaccine candidates across various indications; the Singapore Economic Development Board and Duke-NUS Medical School, specifically for the LUNAR-COV19 vaccine; and Millennium Pharmaceuticals, Inc., focused on discovering siRNA medicines for non-alcoholic steatohepatitis (NASH). Founded in 2013, Arcturus Therapeutics maintains its corporate headquarters in San Diego, California.
ARCT Dividend & DRIP — Frequently Asked Questions
Does ARCT pay a dividend?
No. Arcturus Therapeutics Holdings Inc. (ARCT) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of ARCT?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does ARCT have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. ARCT has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to ARCT
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full ARCT DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ARCT position with:
🌍 ARCT Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold ARCT.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 ARCT Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 ARCT Dividend Payment Schedule
ARCT pays quarterly — 4 times per year. Ex-div: —.
📊 ARCT vs Healthcare Benchmarks
How ARCT compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ARCT sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ ARCT Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-06-05 | 15,000 | $7.30 | $109.5K | ||
| A-Award | 2026-06-05 | 15,000 | $7.30 | $109.5K | ||
| A-Award | 2026-06-05 | 15,000 | $7.30 | $109.5K | ||
| A-Award | 2026-06-05 | 15,000 | $7.30 | $109.5K | ||
| A-Award | 2026-06-05 | 15,000 | $7.30 | $109.5K | ||
| A-Award | 2026-06-05 | 15,000 | $7.30 | $109.5K | ||
| A-Award | 2026-06-05 | 15,000 | $7.30 | $109.5K | ||
| A-Award | 2026-05-01 | 100,000 | $8.63 | $863.0K | ||
| A-Award | 2025-12-17 | 10,000 | $6.52 | $65.2K | ||
| A-Award | 2025-12-17 | 54,000 | $6.52 | $352.1K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare ARCT with peers: ARCT vs ACHV · ARCT vs AVIR · ARCT vs FHTX
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where ARCT earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ARCT dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Arcturus Therapeutics Holdings Inc. (ARCT) is currently trading at $9.84, 45% below its 52-week high. It does not currently pay a regular dividend.
Does ARCT Pay a Dividend? Arcturus Therapeutics Holdings Inc. Dividend Status
Arcturus Therapeutics Holdings Inc. (ARCT) is a healthcare stock trading at $9.84. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest ARCT News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
Projected your ARCT DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.